How to Invest in a Tech-Powered Pharmacy That Aims to Upend the $480B Retail Industry

Disclosure: Our objective is to characteristic services and products that we expect you’ll be able to to find attention-grabbing and helpful. If you buy them, Entrepreneur would possibly get a small proportion of the income from the sale from our trade companions.

Amazon can carry just about the rest from an air bed to a Nerf gun to thumbtacks proper to the doorstep inside 24 hours. GrubHub can land potstickers or sandwiches or a contemporary salad there in a question of mins too. So why can’t you get a competent and rapid door-to-door supply on one thing chances are you’ll in point of fact want? Something like…prescribed drugs?


That’s the place NowRx is available in. The tech-powered pharmacy chain gives a easy, hassle-free solution to get your prescriptions delivered in hours at no additional price. Founded in Northern California, NowRx has regularly grown to over 8 places and $25M in annualized income as of November. Now the corporate is poised for fast nationwide enlargement and enlisting buyers who see the promise of disrupting the $480 billion retail pharmacy business

The key to NowRx’s luck? Proprietary tool and robotics plus minimum overhead expense that  in the long run results in a awesome buyer revel in.

And that superiority is supported through each sufferers and medical doctors. Where different pharmacy supply competition have garnered an alarming selection of 1-star Yelp opinions (Amazon Pill Pack at 80 p.c and Capsule at 32 p.c) NowRx has gained 1-star opinions not up to 1 p.c of the time. In reality, all 8 of NowRx’s places lately grasp an improbable 5.0 ranking from Yelp reviewers.

The NowRx style is strangely easy. It begins with sufferers or medical doctors sending a prescription to their native NowRx – the similar as they’d another pharmacy. However, in contrast to different pharmacies that use guide processes and older tool, NowRx makes use of a proprietary pharmacy control tool “QuickFill” and meting out robotics to obtain, procedure, bottle, and dispense the prescription in beneath 30 seconds – all whilst minimizing mistakes that produce delays like insurance coverage problems, miscommunication with physicians, and many others. 

Once NowRx confirms your order and cope with, they pass the additional mile through providing loose supply proper to a affected person’s house. It’s promised to be in your doorstep in two to 4 hours, or inside simply 60 mins for a $5 expedited order. Meanwhile, the client simplest can pay their insurance coverage copay to obtain that additional to hand house supply.

That intriguing recipe for luck has already generated huge passion for the corporate’s funding rounds, as greater than 10,000 other people have bought stocks since they become to be had on SeedInvest in 2016. Over that point, NowRx’s proportion worth has greater 1,650 p.c and it seems like there can be a lot extra space to develop.

In 2021, NowRx additionally expanded their choices to incorporate telehealth products and services that display promising expansion. From Q1 to Q3, income from telehealth products and services by myself noticed 1,081 p.c expansion offering any other important expansion road for the corporate. 

NowRx seems poised for enormous expansion and may be offering some buyers an overly promising alternative as they appear to amplify nationally. The corporate is lately elevating a file $73M via fairness crowdfunding on SeedInvest and Investor Place lately highlighted the corporate as 1 of the 7 Best Startups to Buy Now From Across the Internet.

You too can be told extra about the NowRx funding alternative during the corporate’s funding web page right here. 

NowRx is providing securities via using an Offering Statement that has been certified through the Securities and Exchange Commission beneath Tier II of Regulation A. A replica of the Final Offering Circular that bureaucracy part of the Offering Statement could also be bought from: NowRx

Source hyperlink

Leave a Reply

Your email address will not be published.